Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Centogene N.V.
(NQ:
CNTG
)
0.3980
+0.0080 (+2.05%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Centogene N.V.
< Previous
1
2
Next >
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
April 11, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
March 09, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in March
March 08, 2023
From
Centogene NV
Via
GlobeNewswire
In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)
February 21, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
February 07, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
February 07, 2023
From
Centogene NV
Via
GlobeNewswire
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
January 10, 2023
From
Twist Bioscience Corporation
Via
Business Wire
CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics
January 09, 2023
Working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for Parkinson’s disease (PD)
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
December 28, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
December 22, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Receives Nasdaq Non-Compliance Notice
December 16, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in December
December 01, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
November 21, 2022
Adding significant financial expertise with an impressive track record in value creation
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in November
November 10, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
November 03, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE to Participate in Upcoming Partnering Conferences in October
October 06, 2022
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics
October 03, 2022
From
Centogene NV
Via
GlobeNewswire
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh
September 08, 2022
Via
ACN Newswire
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics
September 05, 2022
Via
ACN Newswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.